alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
II 

113TH CONGRESS 

1ST SESSION S. 806 

To amend part B of title XVIII of the Social Security Act to exclude 

customary prompt pay discounts from manufacturers to wholesalers from 

the average sales price for drugs and biologicals under Medicare. 

IN THE SENATE OF THE UNITED STATES 

APRIL 24, 2013 

Mr. ROBERTS (for himself, Ms. STABENOW, Mr. CASEY, and Mr. BROWN) introduced the following bill; which was read twice and referred to the Committee on Finance 

A BILL 

To amend part B of title XVIII of the Social Security 

Act to exclude customary prompt pay discounts from 

manufacturers to wholesalers from the average sales 

price for drugs and biologicals under Medicare. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


jbell on DSK7SPTVN1PROD with BILLS
2 

•S 806 IS

1 SECTION 1. EXCLUDING CUSTOMARY PROMPT PAY DIS2 COUNTS FROM MANUFACTURERS TO WHOLE3 SALERS FROM THE AVERAGE SALES PRICE 

4 FOR MEDICARE PAYMENTS FOR DRUGS AND 

5 BIOLOGICALS. 

6 (a) IN GENERAL.—Section 1847A(c)(3) of the Social 

7 Security Act (42 U.S.C. 1395w–3a(c)(3)) is amended— 

8 (1) in the first sentence, by inserting ‘‘(other 

9 than customary prompt pay discounts extended to 

10 wholesalers)’’ after ‘‘prompt pay discounts’’; and 

11 (2) in the second sentence, by inserting ‘‘(other 

12 than customary prompt pay discounts extended to 

13 wholesalers)’’ after ‘‘other price concessions’’. 

14 (b) EFFECTIVE DATE.—The amendments made by 

15 this section shall apply to drugs and biologicals that are 

16 furnished on or after January 1, 2014. 

Æ 


jbell on DSK7SPTVN1PROD with BILLS
#### ANCHORAGE, an Alaskan municipal corporation, Appellant, v. Dorothy BABINEC, as Executrix of the Estate of Edward M. Babinec, Richard Ireland, Randy Kirkeby, Steve Pearson, d/b/a Dairy Queen, Appellees.

No. S-4404.

Supreme Court of Alaska.

Feb. 7, 1992.

*1249Ronald L. Baird, Bradbury, Bliss & Rior-dan, Anchorage, for appellant.

Neil T. O’Donnell, Atkinson, Conway & Gagnon, Anchorage, for appellees.

Before RABINOWITZ, C.J., and BURKE, MATTHEWS, COMPTON and MOORE, JJ.

OPINION

PER CURIAM.

I

The award for attorneys’ fees incurred by the appellees prior to the formal commencement of the present action was not an abuse of the court’s discretion.

II

The record does not support the allocation of 69% of the attorneys’ fees incurred prior to July 1, 1988, for work done by attorneys Vandiver and Guetschow, to the condemnation proceeding. The methodology used to make the allocation was speculative and wholly arbitrary. The allocation must, therefore, be set aside.

III

Although Anchorage argues that the fees awarded for the months of July, 1988, through May, 1990, were excessive, it does not complain that any particular charges were for work that was unnecessary, unreasonable, or unrelated to the condemnation proceeding. Since full attorneys’ fees are the norm under Alaska Civil Rule 72(k), *Triangle, Inc. v. State,*632 P.2d 965, 970 (Alaska 1981), we are unable to say that the court abused its discretion in awarding the full amount of the attorneys’ fees incurred during this time period.

IV

The superior court erred in basing part of its award for attorneys’ fees upon the contingent fee agreement between the property owners and their lawyer. Attorneys’ fees awarded under Civil Rule 72(k) “shall be commensurate with the *time*committed by the attorney to the case.” Rule 72(k), Alaska R.Civ.P. (emphasis added). We remand on this issue with instructions: after determining the actual amount of time spent on the case, the court is to adjust its award using the attorney’s standard hourly rate, provided that the amount of the award, thus calculated, does not exceed that which is reasonable in light of the work done.

V

Each party will bear its own costs and attorney’s fees in this appeal.

AFFIRMED IN PART, REVERSED IN PART, AND REMANDED.
DEFENSE FINANCE AND ACCOUNTING SERVICE 

U.S. Military Retired Pay 

8899 E 56th Street 

Indianapolis, IN 46249-1200 

www.dfas.mil/retiredmilitary.html 

To whom it may concern:

Thank you for contacting the Defense Finance and Accounting Service. We are committed 

to providing continuing support to the families and beneficiaries of our retired members. The 

following information is being sent in reply to your inquiry regarding your military retired pay 

account, specifically the taxability of your payments under the Strickland Decision. 

According to a ruling from the Internal Revenue Service (IRS), military retirees may receive 

the tax benefit derived from retroactive awards of Department of Veterans Affairs (VA) disability 

compensation. When a retiree receives an initial award, or a retroactive increase in disability 

compensation from the VA, the retroactive portion of the compensation may be excluded from the 

member’s taxable retired pay. The portion of military retired pay that is reduced due to receipt of 

VA disability compensation is referred to as the “VA Waiver.” 

For initial awards, the retroactive portion is the disability compensation entitlement from the 

effective date shown on the VA award letter through the day before the reduction of retired pay. 

For increases in awards, the retroactive portion is the difference between the increased 

award and the amounts by which retired pay had been reduced. This includes payments from the 

effective date of the increased award, as shown on the VA award letter, through the day before the 

reduction of retired pay. The amount you exclude may not exceed your monthly taxable retired 

military pay for any given month. 

If your retired pay was reduced after the effective date of the award, you may exclude the 

retroactive portion when you file your annual federal income tax return. We suggest that you attach 

copies of the VA award letter(s), along with your Form 1099-R, to your tax return to substantiate 

your entitlement to the exclusion. In addition, it may benefit you to file amended tax returns for any 

previous years in which retroactive disability compensation was awarded. Consult the IRS to 

determine the years you may file amended returns. 

You may reference IRS Ruling 78-161, known as the Strickland Decision, when contacting 

your local IRS office. They will assist you in obtaining any tax benefit due. 
2

We thank you for your service to our country. Further information about retired military 

pay can be found at our website. You can also contact one of our customer care representatives at 

800-321-1080 or 216-522-5955, between 8:00 a.m. and 5:00 p.m., Eastern Standard Time, Monday

through Friday, write to us at the address above, or fax to 800-469-6559.

 Sincerely, 

Retired and Annuitant Pay
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

JORGE ANTONIO LUNA

- BAUTISTA, AKA Jorge Antonio Bautista,

Petitioner,

v.

LORETTA E. LYNCH, Attorney General,

Respondent. No. 14

- 73249

Agency No. A076

- 606

- 354

MEMORANDUM *

On Petition for Review of an Order of the Board of Immigration Appeals

Submitted August 16 , 2016 **

Before: O’SCANNLAIN, LEAVY, and CLIFTON , Circuit Judges.

Jorge Antonio Luna

- Bautista, a native and citizen of Mexico , petitions for

review of the Board of Immigration Appeals ’ (“BIA”) order dismissing his a ppeal

from an immigration judge’ s decision denying his application for withholding of

removal and protection under the Convention Against Torture (“CAT”). We have

* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36

- 3.

** The panel unanimously concludes this case is suitable for decision without oral argument. See Fed. R. App. P. 34(a)(2). 

# FILED

AUG 24 2016

MOLLY C. DWYER, CLER K

U.S. COURT OF APPEAL S2 14

- 73249

jurisdiction under 8 U.S.C. § 1252. We review for substantial evidence the

agency’s factual findings, Silaya v. Mukasey , 524 F.3d 1066, 1070 (9th Cir. 2008),

and we deny the petition for review.

Substantial evidence supports the BIA’s determination that Luna

- Bautista

faile d to establish a fear of future persecution on account of a protected ground.

See Parussimova v. Mukasey , 555 F.3d 734, 740

- 41 (9th Cir. 2008) (under the

REAL ID Act, an applicant must prove a protected ground is at least “ one central

reason ” for persecut ion) . Thus, Luna

- Bautista’s withholding of removal claim

fails. See Zetino v. Holder , 622 F.3d 1007, 1015

- 16 (9th Cir. 2010).

Substantial ev idence also supports the BIA’ s denial of Luna

- Bautista’s CAT

claim because he failed to demonstrate it is more likely than not he would be

tortured by or with the consent or acquiescence of a public official in Mexico

. See

Silaya , 524 F.3d at 1073.

PETITION FOR REVIEW DENIED.
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[S. 778 Introduced in Senate (IS)]

113th CONGRESS
  1st Session
                                 S. 778

   To authorize the Secretary of Veterans Affairs to issue cards to 
    veterans that identify them as veterans, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 23, 2013

 Mr. Burr (for himself and Mr. Begich) introduced the following bill; 
which was read twice and referred to the Committee on Veterans' Affairs

_______________________________________________________________________

                                 A BILL

 
   To authorize the Secretary of Veterans Affairs to issue cards to 
    veterans that identify them as veterans, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. AUTHORITY TO ISSUE VETERANS ID CARDS.

    (a) Authority.--
            (1) In general.--The Secretary of Veterans Affairs may 
        issue a card to a veteran that identifies the veteran as a 
        veteran and includes a photo of the veteran and the name of the 
        veteran.
            (2) No requirement for enrollment or receipt of benefits.--
        The Secretary may issue a card under paragraph (1) to a 
        veteran, notwithstanding whether such veteran is--
                    (A) enrolled in the system of annual patient 
                enrollment established under section 1705(a) of title 
                38, United States Code; or
                    (B) in receipt of educational assistance, 
                compensation, or pension under laws administered by the 
                Secretary.
            (3) Designation.--A card issued under paragraph (1) may be 
        known as a ``Veterans ID Card''.
    (b) Recognition of Veterans ID Cards for Reduced Pricing of 
Pharmaceuticals and Consumer Products.--The Secretary may work with 
national retail chains that offer reduced prices on pharmaceuticals and 
consumer products to veterans to ensure that such retail chains 
recognize cards issued under subsection (a)(1) for purposes of offering 
reduced prices on pharmaceuticals and consumer products.
    (c) Veteran Defined.--In this section, the term ``veteran'' has the 
meaning given the term in section 101 of title 38, United States Code.
                                 <all>
```
Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)

In connection with this Report on Form 10-Q for the quarterly period ended June 30, 2020 (the "Report") of Garrison Capital Inc. (the "Registrant"), as filed with the Securities and Exchange Commission on the date hereof, I, Daniel Hahn, Chief Financial Officer of the Registrant, hereby certify, to the best of my knowledge, that:

|   | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------|

 

| /s/ Daniel Hahn         |
|-------------------------|
| Daniel Hahn             |
| Chief Financial Officer |
| August 10, 2020         |
EXHIBIT
10.1


November 4, 2016


 


Mr. Peter Lynch


22060 East Arbor Drive


Aurora CO, 80016


 


Dear Peter,


 


We are pleased
to offer you the position of Chief Financial Officer ("CFO"). Your annual
compensation will be $300,000 paid on the standard pay
cycle of the company. As a CFO, you will be a part of the bonus
program with a yearly bonus potential of $100,000 based on the achievement on
mutually agreeable objectives to be determined between you
and your supervisor. As CFO, at this time, you
will report to Ryan Drexler, the Executive Chairman of the Board and Interim
CEO/President.


Additional Compensation:


		·	You will receive l % of the outstanding equity in common stock options, priced at the market
value as of you hire date with a vesting schedule:



		o	1/3 after one year, and



		o	the remaining pro rata quarterly over the following 2 years;



		·	$50,000 sign-on bonus which will be payable within five
(''5") days from the hire date;



		·	If the company experiences change of control, defined as the purchase or sale of



more than 50% of the outstanding equity of the
company, you will receive a 12-month severance package as well as an immediate vesting of any unvested options.


 


You will also be eligible to participate in the following
MusclePharm benefits:


 


Benefits:
Standard MusclePharm provided benefits for full-time employees, currently include the following:


 


		•	40l (k) retirement account after Six Months of employment
with a 4% company match, MusclePharm enrolls
eligible employees on a Monthly basis.



		•	Health, Dental, Vision and Life & Disability
Insurance (1 month after the l St) MusclePharm covers 100%
of the employee' s premium cost, while employee is responsible for 100%
of spouse and dependents premium.



		•	Three days of sick leave



 


 


 


 


 


 


 




     


     


    


 


 


 


 


 


		•	After 90 days you will accrue up to 4 weeks of paid vacation per year.



		•	US holidays recognized by MusclePharm
are effective immediately



		•	$1,000 monthly car allowance



 


 


All employees of MusclePharm
are employed at will and, thus, either you or MusclePharm may terminate the employment
relationship at any time, with or without cause. In addition, all of the benefits listed above may
be changed from time to time, at the sole discretion of MusclePharm.


We are pleased to
welcome you to MusclePharm and we look forward to accomplishing great success together. Please sign below to accept this offer
and plan to report to work on December 1, 2016.


 


 


Sincerely,


/s/ Sarah Jeffers


Sarah Jeffers


Human Resources Manager


 


 


Acceptance of Job Offer:


 


/s/ Peter Lynch


 


 


Print Name: Peter Lynch


 


 


Date: November 7, 2016
#### The People of the State of New York, Respondent, v Sun Choi, Appellant.

Judgment, Supreme Court, New York County (Edward McLaughlin, J.), rendered on February 8, 1989, convicting defendant, after a plea of guilty, of one count of Criminal Sale of a Controlled Substance in the second degree, and sentencing him to an indeterminate term of imprisonment of 3 years to life, is unanimously affirmed.

Defendant asserts on appeal that the plea was not sufficiently supported by a factual basis and that the Court failed to specifically inform him of each of his *Boykin*rights *(Boykin v Alabama,*395 US 238). We disagree.

Review of the plea allocution shows that the plea was knowing and voluntary *(People v Harris,*61 NY2d 9; *see, People v Nixon,*21 NY2d 338, *cert denied sub nom. Robinson v New York,*393 US 1067), and that there was a sufficient factual basis to support the plea *(People v La Porte,*41 AD2d 863). The validity of a plea does not hinge on a catechismic recital of rights, but on whether the plea as a whole was knowing and voluntary *(People v Harris, supra).*Concur—Sullivan, J. P., Rosenberger, Wallach, Asch and Kassal, JJ.
Exhibit 32.1



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002



In connection with the Quarterly Report on Form 10-Q of Monroe
Capital Corporation (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2015, as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Theodore L. Koenig, Chief Executive Officer
of the Company, and I, Aaron D. Peck, Chief Financial Officer of the Company, each certify, pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to our knowledge:



| | 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
| | -- | ---------------------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------



Date: November 9, 2015



| | /s/ Theodore L. Koenig                                        
| | --------------------------------------------------------------
| | Theodore L. Koenig                                            
| | Chairman, Chief Executive Officer and Director                
| | (Principal Executive Officer)                                 
| | Monroe Capital Corporation                                    
| |                                                               
| | /s/ Aaron D. Peck                                             
| | Aaron D. Peck                                                 
| | Chief Financial Officer, Chief Investment Officer and Director
| | (Principal Financial and Accounting Officer)                  
| | Monroe Capital Corporation
Monitoring Locations 

Data Summary

Monitor 2012 4th Max (ppm) 2011 4th Max (ppm) 2010 4th Max (ppm) 2010-2012 Design Value (ppm)

Pechanga 0.075 n/a n/a n/a

Temecula 0.077 0.082 n/a 0.079

Lake Elsinore 0.087 0.092 0.086 0.088
An official website of the United States government         Here's how you know         
**Official websites use .mil**
A **.mil** website belongs to an official U.S. Department of Defense organization in the United States.
**Secure .mil websites use HTTPS**
 A **lock (lock )** or **https://** means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.

Skip to main content (Press Enter).

Defense Intelligence AgencyCOMMITTED TO EXCELLENCE IN DEFENSE OF THE NATION

Search
Search

Search
                    - Facilities Operating Status
                    - Employee Resources

-  Home		 
-  About    -  FAQs             
  -  Organization      -  Locations             
    -  Missile and Space Intelligence Center             
    -  Joint Military Attache School             
    -  Joint Military Intelligence Training Center 
  -  Office of the Inspector General             
  -  Equal Opportunity & Diversity             
  -  Military Integration Office             
  -  History      -  DIA Museum             
    -  George Washington Letters             
    -  Directors of DIA             
    -  The Historians 
  -  Patriots Memorial             
  -  Sexual Assault Prevention and Response             
  -  Contact Us 
-  News & Features    -  Articles             
  -  Videos             
  -  DIA in the News             
  -  Threat Reports             
  -  Photo Gallery             
  -  No FEAR             
  -  Podcasts             
  -  DIA Comics 
-  Careers & Opportunities    -  Career Fields      -  Analysis             
    -  Counterintelligence             
    -  Finance & Acquisition             
    -  Human Intelligence             
    -  Human Services             
    -  Information Technology             
    -  Inspector General             
    -  Legal             
    -  Mission Management             
    -  Office Management & Infrastructure             
    -  Science & Technology             
    -  Security 
  -  Search Vacancies             
  -  Apply to DIA             
  -  Hiring Process             
  -  Internships             
  -  Veteran Programs 
-  Business    -  Contractor Personnel Security             
  -  SIA3             
  -  SITE III             
  -  Innovation             
  -  NeedipeDIA             
  -  Office of Small Business Programs             
  -  Small Business FAQs 

HOMENEWS & FEATURES

Search

Search

                            - All Images 
                            - Other 

                            - Upload Date
                            - Photo Date
                            - Title

Clear Search5 results found.
Exhibit 32

Certification of CEO and CFO Pursuant to

18 U.S.C. Section 1350,

as Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly
Report on Form 10-Q of TPG Specialty Lending, Inc. (the Company) for the quarter ended June 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the Report), Michael Fishman, as Chief
Executive Officer of the Company, and John Viola, as Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                    |  |                        
|------------------- |  | -----------------------
|/s/ Michael Fishman
|Name:               |  | Michael Fishman        
|Title:              |  | Chief Executive Officer
|Date:               |  | August 12, 2011        
|                   
|/s/ John E. Viola  
|Name:               |  | John E. Viola          
|Title:              |  | Chief Financial Officer
|Date:               |  | August 12, 2011        



19